Following the company’s most recent acquisition, Haywood analyst Neal Gilmer has maintained his “Buy” rating on Organigram.
On March 31, in a research update to clients, Treiber maintained his “Hold” rating and price target of (US) $4.00 on BlackBerry. On April 2, BlackBerry reported its Q4 and fiscal 2024 results. In the ...
HEALWELL AI has made an acquisition that will present the company with immediate upsell opportunities., says Raymond James ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results